Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its Mobility.
Animals
Breast Neoplasms
/ drug therapy
Cell Proliferation
/ drug effects
Cinnamates
/ pharmacology
Drug Resistance, Neoplasm
Estrogen Receptor Antagonists
/ pharmacology
Female
Fulvestrant
/ pharmacology
HEK293 Cells
Heterografts
Humans
Indazoles
/ pharmacology
Ligands
MCF-7 Cells
Mice
Mice, Inbred NOD
Mice, Nude
Mice, SCID
Polymorphism, Single Nucleotide
Proteolysis
/ drug effects
Receptors, Estrogen
/ antagonists & inhibitors
Signal Transduction
/ drug effects
Transcription, Genetic
/ drug effects
ER
SERD
breast cancer
chromatin
estrogen receptor
fulvestrant
immobilization
selective ER downregulator
transcription
Journal
Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066
Informations de publication
Date de publication:
08 08 2019
08 08 2019
Historique:
received:
29
08
2018
revised:
28
03
2019
accepted:
17
06
2019
pubmed:
30
7
2019
medline:
10
5
2020
entrez:
30
7
2019
Statut:
ppublish
Résumé
Estrogen receptor-positive (ER
Identifiants
pubmed: 31353221
pii: S0092-8674(19)30689-0
doi: 10.1016/j.cell.2019.06.026
pii:
doi:
Substances chimiques
3-(4-(2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid
0
Cinnamates
0
Estrogen Receptor Antagonists
0
Indazoles
0
Ligands
0
Receptors, Estrogen
0
Fulvestrant
22X328QOC4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
949-963.e18Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.